Gennari C, Galli M, Montagnani M, D'Amore I
Quad Sclavo Diagn. 1976 Mar;12(1):15-38.
Many hormones initiate their biologic actions by augmenting the intracellular concentrations of 3',5'-adenosine monophosphate (cyclic AMP). The nucleotide has been found in body fluids; its determination in plasma and urine can be performed by a rapid, simple and specific method: the cyclic AMP assay kit of the Radiochemical Centre (Amersham, England). The assay is based on the competition between unlabelled cAMP and a fixed quantity of the tritium labelled compound for binding to a bovine muscle protein which has a high specificity and affinity for cAMP. Different factors must be considered in evaluating the 24 h urinary content of the nucleotide: the renal or extrarenal origin of cAMP and the functional status of the kidneys. In basal conditions the urinary cAMP excretion is significantly correlated with creatinine excretion (n = 67; r = 0.47; p less than 0.001) thus confirming that the most part of cAMP excreted is derived from the plasma by glomerular filtration. Parathyroid hormone (PTH) stimulates adenylate cyclase predominantly in the renal cortex, whereas vasopressin (ADH) stimulated the enzyme in the medulla; thus PTH and ADH could increase the amount of cAMP in the urine from the renal source. In a case of diabetes insipidus and infusion of ADH caused a prompt rise in cAMP urinary excretion. In 5 normals an infusion of bovine synthetic parathyroid hormone caused an increased excretion of cAMP that preceded the phosphaturic response. An infusion of salmon synthetic calcitonin caused a rise in phosphate excretion and no increase in cAMP urinary content. As it concerns the two calciotopic hormones, PTH and CT, it is reasonable to assume that renal receptors are distinct. The 24 h urinary excretion of cAMP in 55 control subjects (3613 +/- 1460 D.S. n moles) was contrasted with the lower excretion in 25 elderly subjects (70-93 years: 1804 +/- 699 n moles), with the high cAMP excretion in a patient with hyperparathyroidism (that fell to normal values following removal of the parathyroid adenoma) and with the low cAMP excretion in patients with primary or surgical hypoparathyroidism. The mean 24 h cAMP excretion in patients with renal insufficiency was significantly decreased when compared to control subjects. These findings and recent reports confirm that the 24 h urinary output of cAMP may be considered an useful index of pharathyroid function in man.
许多激素通过提高细胞内3',5'-腺苷单磷酸(环磷酸腺苷)的浓度来启动其生物学作用。已在体液中发现这种核苷酸;其在血浆和尿液中的测定可通过一种快速、简单且特异的方法进行:放射化学中心(英国阿默舍姆)的环磷酸腺苷检测试剂盒。该检测基于未标记的环磷酸腺苷与固定量的氚标记化合物竞争结合对环磷酸腺苷具有高特异性和亲和力的牛肌肉蛋白。在评估核苷酸的24小时尿含量时必须考虑不同因素:环磷酸腺苷的肾源性或肾外源性以及肾脏的功能状态。在基础状态下,尿中环磷酸腺苷排泄与肌酐排泄显著相关(n = 67;r = 0.47;p<0.001),从而证实排泄的大部分环磷酸腺苷是通过肾小球滤过从血浆衍生而来。甲状旁腺激素(PTH)主要刺激肾皮质中的腺苷酸环化酶,而血管加压素(抗利尿激素,ADH)刺激髓质中的该酶;因此,PTH和ADH可增加来自肾脏的尿中环磷酸腺苷的量。在尿崩症患者中,输注ADH导致尿中环磷酸腺苷排泄迅速增加。在5名正常人中,输注牛合成甲状旁腺激素导致环磷酸腺苷排泄增加,且早于磷尿反应。输注鲑鱼合成降钙素导致磷酸盐排泄增加,而尿中环磷酸腺苷含量未增加。关于两种钙调节激素PTH和CT,可以合理推测肾脏受体是不同的。55名对照受试者(3613±1460标准差n摩尔)的24小时尿中环磷酸腺苷排泄与25名老年受试者(70 - 93岁:1804±699 n摩尔)较低的排泄形成对比,与一名甲状旁腺功能亢进患者(甲状旁腺腺瘤切除后降至正常水平)中环磷酸腺苷的高排泄以及原发性或手术性甲状旁腺功能减退患者中环磷酸腺苷的低排泄形成对比。与对照受试者相比,肾功能不全患者的24小时平均环磷酸腺苷排泄显著降低。这些发现和近期报告证实,24小时尿中环磷酸腺苷排出量可被视为人体甲状旁腺功能的一个有用指标。